Cordis shareholders approved Johnson & Johnson’s $1.8-billion...
Times Staff and Wire Reports
Cordis shareholders approved Johnson & Johnson’s $1.8-billion takeover offer. . . . Chantal Pharmaceutical has missed a second SEC filing deadline.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
